Plain-English translation of NCT07616258 on ClinicalTrials.gov ↗ · Source last updated ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether breast cancer patients need as many hospital follow-up visits as currently recommended. After completing your cancer treatment, you would be randomly placed into one of two groups: one that continues the standard five-year schedule of clinic visits, or one that stops hospital visits after two years but continues yearly mammograms. The study aims to see if the shorter visit schedule is just as safe and possibly more convenient for patients.
After successful breast cancer treatment, patients typically have frequent hospital visits for several years. This trial exists to find out whether patients can safely have fewer clinic visits while still getting the important yearly mammogram screening, which could reduce unnecessary time away from work and family.
You likely qualify if…
You likely don't qualify if…
If you join, you'll be randomly assigned to either continue your usual hospital visits over five years, or switch to a new plan with hospital visits only for the first two years. Either way, you'll continue your yearly mammogram screening and have access to your breast care nurse by phone whenever you need support. Each year, you'll complete a short questionnaire (in person or by phone) to tell researchers how you're feeling and what you think of the follow-up plan. The whole study lasts five years from when you finished your cancer treatment.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Ireland